Herceptin Targets HER2-Positive Breast Cancer

HER2-positive breast cancer accounts for about one-third of all cases of breast cancer. It is aggressive and often metastatic, spreading beyond the original tumor site. Herceptin is a targeted biologic therapy that is added to your chemotherapy infusions, which hunts down only those cancer cells that have HER2/neu receptors on their outer surface. Herceptin attaches to the HER2 receptors and blocks the growth signal, preventing more cell division, and slowing the progress of the cancer. This drug extends survival for you, if you have HER2/neu positive breast cancer.

• Herceptin as a Breast Cancer Treatment
• About HER2-Positive Breast Cancer